Potassium iodide 65 MG Oral Tablet [Iosat] — RxCUI 1423814
RxNorm drug concept · Semantic branded drug
RxCUI 1423814
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1423814
Official namePotassium iodide 65 MG Oral Tablet [Iosat]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asIosat 65 MG Oral Tablet; K+ Iodide 65 MG Oral Tablet [Iosat]; Pot Iodide 65 MG Oral Tablet [Iosat]
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Potassium Iodide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's reasonable to have it on hand if public health authorities in your area recommend it — especially if you live near a nuclear facility. But the key rule is: only take it when p...
- Should I keep potassium iodide at home just in case, or only take it if there's actually an emergency?
- No — taking more than one dose every 24 hours will not give you more protection. Your thyroid can only hold a certain amount of iodine at a time, so once it's full, extra doses jus...
- What if I take an extra dose? Will it protect me better?
🕸️ Concept Web — How Potassium iodide 65 MG Oral Tablet [Iosat] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Potassium iodide 65 MG Oral Tablet [Iosat]
RxCUI 1423814 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Potassium iodide
8597IN
-
Potassium iodide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Iosat
1111700BN
-
Iosat
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Potassium iodide Oral Tablet
375919SCDF -
Potassium iodide Oral Product
1161057SCDG -
Potassium iodide Pill
1161058SCDG -
Potassium iodide Oral Tablet [Iosat]
1111702SBDF -
Iosat Oral Product
1176152SBDG -
Iosat Pill
1176153SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Potassium iodide Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Potassium iodide 65 MG Oral Tablet
430174SCD -
Potassium iodide 65 MG
451029SCDC -
Potassium iodide 65 MG [Iosat]
1423813SBDC
-
Potassium iodide 65 MG Oral Tablet
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Potassium iodide 65 MG Oral Tablet
SCD · 430174 -
Potassium iodide 65 MG
SCDC · 451029 -
Potassium iodide Oral Tablet
SCDF · 375919 -
Potassium iodide Oral Product
SCDG · 1161057 -
Potassium iodide Pill
SCDG · 1161058
Brand-Name Concepts
-
Potassium iodide 65 MG [Iosat]
SBDC · 1423813 -
Potassium iodide Oral Tablet [Iosat]
SBDF · 1111702 -
Iosat Oral Product
SBDG · 1176152 -
Iosat Pill
SBDG · 1176153 -
Iosat
BN · 1111700
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 1423814 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 51803-0002-01 | 20 TABLET in 1 PACKAGE (51803-002-01) | IOSAT | Anbex Inc. | 2013-05-01 |
| 51803-0002-02 | 14 TABLET in 1 PACKAGE (51803-002-02) | IOSAT | Anbex Inc. | 2015-11-23 |
Observed labelers:
Anbex Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.